Chemours Announces Board Changes
Ticker: CC · Form: 8-K · Filed: Mar 10, 2025 · CIK: 1627223
| Field | Detail |
|---|---|
| Company | Chemours Co (CC) |
| Form Type | 8-K |
| Filed Date | Mar 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, governance
TL;DR
Chemours board shake-up: Vergnani out, Lown in.
AI Summary
The Chemours Company announced on March 9, 2025, a change in its board of directors. Specifically, it reported the departure of director Mark P. Vergnani and the election of new director Christopher J. Lown. These changes are effective as of March 9, 2025.
Why It Matters
Changes in a company's board of directors can signal shifts in strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing pertains to routine board member changes and does not involve financial performance or significant operational shifts.
Key Players & Entities
- The Chemours Company (company) — Registrant
- Mark P. Vergnani (person) — Departing Director
- Christopher J. Lown (person) — Newly Elected Director
- March 9, 2025 (date) — Effective date of changes
FAQ
Who has departed from The Chemours Company's board of directors?
Mark P. Vergnani has departed from The Chemours Company's board of directors.
Who has been elected as a new director to The Chemours Company's board?
Christopher J. Lown has been elected as a new director to The Chemours Company's board.
When are these board changes effective?
The changes are effective as of March 9, 2025.
What is the filing date of this 8-K report?
The filing date of this 8-K report is March 10, 2025.
What is the principal executive office address for The Chemours Company?
The principal executive office address is 1007 Market Street, Wilmington, Delaware 19801.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 10, 2025 by Mark P. Vergnani regarding Chemours Co (CC).